Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Quote

Third-party claim

“These promising findings represent a major step forward in our goal to bring a paradigm-shifting treatment to the millions of patients who are profoundly impacted by GAD”
· "Can Anxiety Can Be Over?": MM-120, an LSD Analog Phase IIb Data in Generalized Anxiety Disorder Released! · substack podcast

Pasted MindMed press release on MM-120 (LSD analog) phase IIb data in generalized anxiety disorder: 7.6-point HAM-A reduction vs placebo at week 4, Cohen's d 0.88. Quote is from CEO Robert Barrow. The author calls the data 'groundbreaking' but adds no forecast of his own.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.